Harnessing the Power of Extracellular Vesicles and Secretomes in Drug Development

Extracellular vesicles (EVs) and secretomes are gaining recognition as transformative tools in drug development, regenerative medicine, and cellular therapeutics. These biological entities hold the potential to revolutionize how we treat diseases by promoting cell-to-cell communication and delivering therapeutic molecules precisely to target tissues.At Waisman Biomanufacturing, we have leveraged twenty years of cellular therapy and traditional bioprocessing manufacturing to support biopharmaceutical companies in developing next-generation extracellular vesicle (EV) and secretome therapies. From custom EV production to scalable secretome manufacturing for Phase 1 and Phase 2 clinical trials, our services ensure the highest quality and compliance standards.

What Are Extracellular Vesicles and Secretomes?

Extracellular vesicles (EVs) are membrane-bound particles released by cells, containing proteins, lipids, RNA, and DNA that help communicate with other cells. They come in multiple forms, such as exosomes, microvesicles, and apoptotic bodies, each with distinct molecular compositions and functions.A secretome refers to the full range of molecules—proteins, cytokines, growth factors, and extracellular vesicles—secreted by cells into their surrounding environment. Together, EVs and secretomes are used in therapeutic research to deliver active agents, modulate immune responses, and promote tissue regeneration.

Applications of EVs and Secretomes in Medicine

These tiny biological packages have shown immense potential in several therapeutic areas1, including:

• Cancer Therapy: Delivering RNA or proteins to inhibit tumor growth or boost immune responses.
• Regenerative Medicine: Promoting tissue repair by delivering growth factors and anti-inflammatory molecules.
• Immune Modulation: Regulating immune responses in autoimmune diseases or transplant rejection.
• Neurological Disorders: Facilitating targeted delivery of molecules to the brain for treating neurodegenerative conditions.

With these exciting developments, biopharma companies are increasingly turning to GMP-compliant EV and secretome manufacturing partners to ensure clinical-grade quality for their novel treatments.

Waisman Biomanufacturing: Your Partner for EV and Secretome Production

Waisman Biomanufacturing offers a comprehensive suite of manufacturing services to support the production and scale-up of extracellular vesicles and secretomes. Our expertise spans every stage of drug development, ensuring that your project meets regulatory requirements and advances smoothly from preclinical testing to clinical trials.

Our EV and Secretome Services

1. Custom Production of Extracellular Vesicle and Secretome Products
   • Tailored production of EVs and production of complex secretomes that contain growth factors, cytokines, and extracellular vesicle based on your project’s unique specifications.
   • Advanced purification techniques to ensure high yield and purity.
   • Scalable solutions to meet the demands of clinical trials.
   • Customizable formulations to suit various therapeutic applications.
   • GMP-compliant processes to meet FDA regulatory standards.
2. Aseptic Fill and Finish Services
   • Sterile packaging of EV and secretome products to ensure product integrity.
   • Customizable container closure systems with your service.
3. Quality Control and Assurance
   • Rigorous quality control procedures to verify EV and secretome product specifications.
   • Advanced analytical testing for consistent potency, purity, and stability of products.
   • Batch-release testing to meet stringent GMP and FDA requirements.
   • Continuous (in-process) monitoring to ensure product integrity and compliance throughout the production process.
4. Regulatory and Quality Compliance
   • Comprehensive chemistry, manufacturing, and control (CMC) documentation to meet FDA guidelines.
   • Availability to cross-reference Type V Drug Master File for facility and equipment information and support IND filings.

Why Choose Waisman Biomanufacturing for EV and Secretome Production?

• GMP-Compliant Manufacturing: We adhere to strict GMP standards to ensure the safety and efficacy of your products.
• Expertise in Cell Therapy and Biologics: Our team has extensive experience with biotherapeutics, including plasmid DNA, recombinant proteins, and microbial vaccines.
• End-to-End Support: From process development to aseptic fill/finish, we offer complete support to bring your therapy to clinical trials.
• Custom Solutions for Unique Needs: We understand that every project is unique. Our services are tailored to meet the specific requirements of your therapeutic innovation.
• Ownership: You will own your processes for later stage development and commercialization.

The Future of EV and Secretome Therapies

The potential of extracellular vesicles and secretomes in medicine is vast, from promoting tissue repair to delivering targeted therapies for cancer and neurological disorders. As these technologies move toward clinical adoption, high-quality manufacturing becomes crucial for ensuring product safety and therapeutic efficacy.At Waisman Biomanufacturing, we are committed to helping biotech companies turn their ideas into life-changing therapies. Whether you're developing a novel cell therapy or scaling up production for clinical trials, our GMP-compliant EV and secretome manufacturing services are designed to meet your needs.

Contact Us Today to Get Started

Are you developing an extracellular vesicle or secretome-based therapy? Partner with Waisman Biomanufacturing to bring your innovation to life. With our cutting-edge manufacturing capabilities and regulatory expertise, we’ll help you navigate the complexities of biomanufacturing and accelerate your journey to market. Contact us today to learn more about how we can support your Phase 1 and Phase 2 clinical trials.